Augustine Lawlor Catalyst Biosciences, Inc. (CBIO) insider trading activity

Augustine Lawlor is of CATALYST BIOSCIENCES, INC.. Currently has a direct ownership of 0 shares of CBIO, which is worth approximately $0. The most recent transaction as insider was on Aug 31, 2023, when has been sold 24 shares (Series Y Preferred Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

AUGUSTINE LAWLOR Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 31 2023	SELL Sale (or disposition) back to the issuer	-	24 Reduced 100.0%	0 Series Y Preferred Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	5,839 Added 19.2%	24,573 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	5,542 Added 22.83%	18,734 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	4,761 Added 26.52%	13,192 Common Stock
Jan 05 2021	BUY Grant, award, or other acquisition	-	3,417 Added 28.84%	8,431 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	-	5,014 Added 50.0%	5,014 Common Stock

Also insider at

LPTX

LEAP THERAPEUTICS, INC. Healthcare

Chief Operating Officer

CSII

Cardiovascular Systems Inc Healthcare

Director